or Try an Advanced Search...

    Metastatic Melanoma Stocks List

    Symbol Grade Name % Change
    AGEN F Agenus Inc. 3.93
    BMY F Bristol-Myers Squibb Company -2.51
    IOVA D Iovance Biotherapeutics, Inc. -0.29
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major
    Related Stock Lists: Melanoma Biopharmaceutical Cancer Cancer Treatment Clinical Medicine Medicine Adoptive Cell Transfer Agenus Alzheimer's Disease Antineoplastic Drugs Atrial Fibrillation Biopharmaceutical Products Biotechnology Breast And Lung Cancer Cancer Cell Cancer Immunotherapy Cancer Immunotherapy Product Cancer Vaccine Carcinoma Cell Therapy

    Related ETFs - A few ETFs which own one or more of the above listed Metastatic Melanoma stocks.

    Symbol Grade Name Weight
    FTXH D First Trust Nasdaq Pharmaceuticals ETF 6.34
    MEDX D Horizon Kinetics Medical ETF 4.71
    WBIY C WBI Power Factor High Dividend ETF 4.34
    XPH D SPDR S&P Pharmaceuticals ETF 3.88
    IHE D iShares U.S. Pharmaceutical ETF 3.84
    View all Metastatic Melanoma ETFs...
    Compare ETFs
    Compare FTXH to MEDX Compare FTXH to XPH Compare XPH to IHE

        Metastatic Melanoma Stocks Recent News

        Date Stock Title
        May 21 BMY Bristol Myers Squibb, Taye Diggs and Schizophrenia Community Partner to Empower People with Schizophrenia Through Live Your PosSCZible Campaign
        May 21 BMY 1 Stock I Wouldn't Touch With a 10-Foot Pole
        May 21 BMY Bristol-Myers says FDA has revised decision date on injected Opdivo
        May 21 BMY Bristol Myers Squibb Announces Updated Action Date by the U.S. Food and Drug Administration for Subcutaneous Nivolumab (nivolumab and hyaluronidase)
        May 18 BMY Bristol-Myers Squibb Company (NYSE:BMY) is a favorite amongst institutional investors who own 79%
        May 17 BMY AbbVie Is 'Successfully Positioned To Absorb Humira Biosimilar Erosion': Analyst
        May 17 BMY The Zacks Analyst Blog Highlights Novavax, Sanofi, Fulcrum Therapeutics, Moderna and Bristol Myers
        May 17 BMY Erasca restructures; Novartis moves to complete MorphoSys deal
        May 17 BMY BMS reports four-year data from psoriasis treatment extension trial
        May 16 BMY Walmart Earnings & the State of the Consumer
        May 16 BMY Biotech Stock Roundup: NVAX, FULC Up on Deals With SNY, Updates From MRNA, BMY
        May 16 BMY New Four-Year Sotyktu (deucravacitinib) Data Demonstrate Durable Response Rates and Consistent Safety in Moderate-to-Severe Plaque Psoriasis
        May 16 IOVA 4 Small-Cap Value Stocks That Could Go Parabolic
        May 16 BMY Bristol Myers (BMY) Gets FDA Nod for Breyanzi Label Expansion
        May 16 AGEN FDA Grants Agenus Type B End-of-Phase 2 Meeting to Discuss BOT/BAL Therapy for Relapsed or Refractory Metastatic Colorectal Cancer
        May 16 BMY FDA approves Bristol Myers Squibb’s Breyanzi for follicular lymphoma
        May 16 BMY Bristol Myers Squibb’s CAR T Cell Therapy Breyanzi Approved by the U.S. Food and Drug Administration for Relapsed or Refractory Follicular Lymphoma
        May 15 BMY Bristol-Myers Squibb Company (BMY) Bank of America Global Healthcare Conference 2024 Transcript
        May 15 BMY Tudor Investment's top buys and sells in Q1
        May 15 BMY Bristol Myers' Breyanzi gains additional indication for follicular lymphoma
        Related Industries: Biotechnology Drug Manufacturers - Major
        Related Stock Lists: Melanoma Biopharmaceutical Cancer Cancer Treatment Clinical Medicine Medicine Adoptive Cell Transfer Agenus Alzheimer's Disease Antineoplastic Drugs Atrial Fibrillation Biopharmaceutical Products Biotechnology Breast And Lung Cancer Cancer Cell Cancer Immunotherapy Cancer Immunotherapy Product Cancer Vaccine Carcinoma Cell Therapy
        Metastatic Melanoma

        Metastatic melanoma is a type of skin cancer that has spread to other parts of the body. It is the most advanced form of melanoma and is usually more difficult to treat than earlier stages of the disease. Metastatic melanoma can spread to the lymph nodes, lungs, liver, brain, and other organs. Treatment options may include surgery, radiation, chemotherapy, immunotherapy, and targeted therapy.

        Browse All Tags